ru24.pro
News in English
Декабрь
2024
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
24
25
26
27
28
29
30
31

What can a wonder drug maker and a phone maker have in common? Their fall from grace

0
Novo Nordisk's reign as Europe's most valuable company is facing a challenge from US rival Eli Lilly. Lilly's weight-loss drug, Zepbound, is gaining market share, while Novo's experimental drug showed less impressive results. This competition mirrors the Nokia-Apple rivalry, raising concerns about Europe's ability to maintain its competitive edge.